summer st re:ce mark approval and launch

Mulling over some old stuff while waiting... and waiting (not long to go)
From:-
January 18, 2012
Sunshine Heart —Initiation of Coverage
Summer Street Research Partners.

"CE Mark approval and launch: SHC submitted a CE Mark application for C-Pulse in December 2011. We anticipate CE Mark approval by the end of the second quarter in 2012. We are modeling a 3Q12 launch at six centers that have prior C-Pulse experience and forecast 10 units will be implanted during 2012. SHC will initially cover six sites in Germany and Italy and estimates that the profits from selling ten devices will cover the initial commercializing costs."

Re ***cover the initial commercialising costs.

Makes me wonder if the extension in Canada is about revenue (and good science).

If 10 in Europe can cover costs whats 20 in Canada doing? Revenue stream to borrow on/ cash flow positive?
If you are doing 20 in Canada sorting out problems and ramp up, 10 in Europe looks a gross underestimation.
If take up in Europe is revised upwards is the US trial going to take 26 months to fill? Significant savings? Cash position? SHC is reimbursed in US in most cases.
If the whole thing is cash flow positive now the big bids must be round the corner.

DYOR still worth thinking about.

Malmanu, uptick could make US buyer keener, see tonight.